Primary sclerosing cholangitis

37,215views

Primary sclerosing cholangitis

IPC 2021

IPC 2021

Helicobacter pylori
Pancreatitis: Pathology review
Pancreatitis: Clinical
Acute pancreatitis
Chronic pancreatitis
Peptic ulcer
Appendicitis
Appendicitis: Clinical
Appendicitis: Pathology review
Biliary colic
Ascending cholangitis
Primary sclerosing cholangitis
Chronic cholecystitis
Acute cholecystitis
Ectopic pregnancy
Pelvic inflammatory disease
Endometriosis
Bowel obstruction
Bowel obstruction: Clinical
Abdominal pain: Clinical
Peritonitis
Aortic aneurysms and dissections: Clinical
Aortic dissections and aneurysms: Pathology review
Diverticulosis and diverticulitis
Kidney stones
Kidney stones: Pathology review
Kidney stones: Clinical
Colorectal cancer: Clinical
Anaphylaxis
Conjunctivitis
Urticaria
Osteoarthritis
Rheumatoid arthritis: Clinical
Rheumatoid arthritis and osteoarthritis: Pathology review
Osteomyelitis
Septic arthritis
Gout
Raynaud phenomenon
Spinal disc herniation
Degenerative disc disease
Legg-Calve-Perthes disease
Lordosis, kyphosis, and scoliosis
Spondylolisthesis
Spondylolysis
Osteoporosis
Ankylosing spondylitis
Bone tumors
Bone tumors: Pathology review
Coronary artery disease: Pathology review
Angina pectoris
Endocarditis
Myocardial infarction
ECG cardiac infarction and ischemia
Pneumothorax: Clinical
Gastroesophageal reflux disease (GERD)
Gastroesophageal reflux disease (GERD): Clinical
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Antituberculosis medications
Asthma
Asthma: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Pneumonia: Clinical
Pediatric lower airway conditions: Clinical
Major depressive disorder
Stress
Suicide
Inflammatory bowel disease: Clinical
Irritable bowel syndrome
Gastroenteritis
Dizziness and vertigo: Clinical
Labyrinthitis
Meniere disease
Lung cancer: Clinical
Pleural effusion: Clinical
Heart failure: Clinical
Urinary tract infections: Clinical
Neisseria gonorrhoeae
Otitis media
Otitis externa
Tympanic membrane perforation
Hypothyroidism and thyroiditis: Clinical
Diabetes mellitus: Clinical
Anemia: Clinical
Pregnancy
Fever of unknown origin: Clinical
Diarrhea: Clinical
Plasmodium species (Malaria)
Sinusitis
Cluster headache
Meningitis
Migraine
Subarachnoid hemorrhage
Tension headache
Headaches: Clinical
Atopic dermatitis
Contact dermatitis
Erythema multiforme
Herpes simplex virus
Impetigo
Poxvirus (Smallpox and Molluscum contagiosum)
Pityriasis rosea
Pediatric infectious rashes: Clinical
Sarcoptes scabiei (Scabies)
Psoriasis
Glaucoma
Bacterial epiglottitis
Upper respiratory tract infection
Laryngitis
Oral candidiasis
Retropharyngeal and peritonsillar abscesses
Epstein-Barr virus (Infectious mononucleosis)
Allergic rhinitis
Influenza virus
Adult brain tumors: Pathology review
Brain abscess
Hyperthyroidism: Clinical
Erectile dysfunction
Sexual dysfunctions: Clinical
Kwashiorkor
Marasmus
Gastrointestinal bleeding: Clinical
HIV (AIDS)
Jaundice: Clinical
Toxidromes: Clinical
Insomnia
Syncope: Clinical
Loa loa (Eye worm)
Toxocara canis (Visceral larva migrans)
Onchocerca volvulus (River blindness)
Ascaris lumbricoides
Anisakis
Angiostrongylus (Eosinophilic meningitis)
Ancylostoma duodenale and Necator americanus
Strongyloides stercoralis
Guinea worm (Dracunculiasis)
Wuchereria bancrofti (Lymphatic filariasis)
Trichinella spiralis
Enterobius vermicularis (Pinworm)
Trichuris trichiura (Whipworm)
Echinococcus granulosus (Hydatid disease)
Diphyllobothrium latum
Paragonimus westermani
Clonorchis sinensis
Schistosomes

Transcript

Watch video only

Content Reviewers

The name “primary sclerosing cholangitis” or PSC, is actually pretty straightforward, primary refers to it not being known to have been caused by anything else, in other words it isn’t secondary to something else.

Sclerosing means hardening of the tissue and cholangitis is inflammation of the bile ducts.

So with PSC we have this fibrosis and inflammation of both the intra- and extra-hepatic ducts, so inside and outside the liver.

As these cells around the bile ducts become inflamed, die, and harden due to fibrosis, you get this like tightening of the ducts in some areas where there’s been serious fibrosis, and then dilation in other areas that aren’t as affected, and this leads to the classic PSC finding of this sort of “beaded” appearance of the bile ducts.

These areas of fibrosis in the bile ducts can also be seen on histology, and looks a bit like an onion skin since you’ve got these concentric rings of fibrosis around the bile duct, so sometimes it’s referred to as “onion-skin fibrosis”.

Again, with PSC, we don’t really know what causes it right? One clue though is that it’s been known to be associated with ulcerative colitis which is an autoimmune disease and crohn’s disease which is immune-system related; knowing that, PSC’s thought to possibly be an autoimmune disorder itself involving the immune system’s T cells attacking and destroying bile duct epithelial cells.

Why they might start doing this, though, is not very well known, and likely happens in people with certain genetic predispositions when they’re exposed to some specific stimuli in their environment.

Certain genetic factors have been linked to developing PSC; studies have shown that patients with PSC tend to have in common specific human leukocyte antigens, or HLAs.

HLAs are these specific markers on cells that tell your body whether these cells are your own cells or someone else’s cells, and sometimes, for reasons that are usually not well known, the body’s immune system might think that certain HLAs or cell surface markers are foreign even when they’re your own, leading to an autoimmune disorder.

Specific HLA’s that have been common among people with PSC are HLA-B8, HLA-DR3, and HLA-DRw52a.

Another piece of supporting evidence for the autoimmune theory is that most patients with PSC have elevated IgM antibody levels in the serum, as well as an antibody called p-ANCA.

P-ANCA stands for perinuclear anti-neutrophil cytoplasmic antibody, so this is a specific antibody that targets antigens in the cytoplasm or nucleus of neutrophils, the perinuclear part means that the antibody targets an antigen around the nucleus.

Here’s an immunofluorescent image of p-ANCAs, the antibodies in this image are shown in orange, and notice they’ve sort of aggregated around the nucleus, meaning that they bind to an antigen around the nucleus.

A very high proportion, as high as 80%, of patients with PSC have this p-ANCA staining pattern.

Symptoms of PSC are similar to the symptoms of obstructive jaundice, since these “beads” or pinched areas are obstructing the flow of bile.

Also, as these epithelial cells lining the ducts die off, bile can now be allowed to leak out past the cells into the interstitial space, where it can access the bloodstream.

Key Takeaways

Primary sclerosing cholangitis (PSC) is a disease of the bile ducts that causes inflammation and obliterative fibrosis of bile ducts inside and/or outside of the liver. This results in scarring of the biliary tree, which impedes the flow of bile to the intestines and can ultimately lead to cirrhosis of the liver, liver failure, and liver cancer. Symptoms of PSC can include fatigue, itching, jaundice, abdominal pain, and weight loss. If left untreated, PSC can lead to liver failure. Definitive treatment is liver transplant, but ursodeoxycholic acid (UDCA help to slow disease progression and alleviate symptoms.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw Hill Professional (2019)
  5. "Primary Sclerosing Cholangitis" New England Journal of Medicine (2016)
  6. "The dynamic biliary epithelia: Molecules, pathways, and disease" Journal of Hepatology (2013)
  7. "Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis" Annals of Hepatology (2014)